Effects of EPA and DHA on Alzheimer's Disease in Mice
Author Information
Author(s): Oye Mintsa Mi-mba Méryl-Farelle, Lebbadi Meryem, Alata Waël, Julien Carl, Emond Vincent, Tremblay Cyntia, Fortin Samuel, Barrow Colin J., Bilodeau Jean-François, Calon Frédéric
Primary Institution: Laval University, Quebec, QC, Canada
Hypothesis
The study investigates whether eicosapentaenoic acid (EPA) provides additional benefits compared to docosahexaenoic acid (DHA) in an animal model of Alzheimer's disease.
Conclusion
Dietary intake of DHA and EPA leads to differential changes in brain fatty acid profiles and reduces tau pathology in a mouse model of Alzheimer's disease.
Supporting Evidence
- DHA and DHA + EPA diets increased n-3 PUFA levels in the brain.
- Both diets reduced soluble phosphorylated tau levels.
- The DHA + EPA diet decreased insoluble phosphorylated tau levels more than the DHA diet.
- EPA levels in the brain increased significantly with the DHA + EPA diet.
- Consumption of DHA and DHA + EPA diets altered brain fatty acid profiles.
Takeaway
Feeding mice with special diets high in DHA and EPA can help their brains stay healthier and reduce signs of Alzheimer's disease.
Methodology
Male and female 3xTg-AD mice were fed different diets for 3 months, and various brain biomarkers were measured.
Potential Biases
Potential bias due to the limited availability of the EPA formulation and the specific dietary conditions.
Limitations
The study did not assess cognitive performance and the formulation of EPA was not standardized.
Participant Demographics
Male and female 3xTg-AD mice aged 13-16 months.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website